A detailed history of Rosenblum Silverman Sutton S F Inc transactions in Zoetis Inc. stock. As of the latest transaction made, Rosenblum Silverman Sutton S F Inc holds 40,525 shares of ZTS stock, worth $7.1 Million. This represents 2.11% of its overall portfolio holdings.

Number of Shares
40,525
Previous 40,545 0.05%
Holding current value
$7.1 Million
Previous $7.03 Million 12.65%
% of portfolio
2.11%
Previous 1.93%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$172.58 - $196.48 $3,451 - $3,929
-20 Reduced 0.05%
40,525 $7.92 Million
Q2 2024

Aug 14, 2024

BUY
$145.54 - $178.83 $133,169 - $163,629
915 Added 2.31%
40,545 $7.03 Million
Q1 2024

May 14, 2024

BUY
$165.67 - $199.94 $6.57 Million - $7.92 Million
39,630 New
39,630 $6.71 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Rosenblum Silverman Sutton S F Inc Portfolio

Follow Rosenblum Silverman Sutton S F Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rosenblum Silverman Sutton S F Inc , based on Form 13F filings with the SEC.

News

Stay updated on Rosenblum Silverman Sutton S F Inc with notifications on news.